Report Published: "United Kingdom Pharmaceuticals & Healthcare Report Q1 2014"
BMI View: The UK government's implementation of an almost 4% price cut on medicines in 2014, under a five-year agreement to slow inflation in the GBP11bn (US$15bn) annual National Health Service (NHS) medicines budget, will work against the country's business environment. The continuation of the Pharmaceutical Price Regulation Scheme (PPRS), which should have been replaced by the value-based pricing (VBP) at the start of 2014, highlights the government's view that medicines are a cost that need to, and will be,...
View full press release